The BRILLIANT program is scrambling to find money to save the project. The purchase of key equipment has stopped.

Just a week had remained before scientists in South Africa were to begin clinical trials of an HIV vaccine, and hopes were high for another step toward limiting one of history's deadliest pandemics.

But when President Trump's cuts to aid funding were announced earlier this year, she and thousands of other HIV-positive ...

There is widespread hope for curbing HIV after the United States Food and Drug Administration (FDA) approved an injectable ...

Bill Gates raises concerns over U.S. aid cuts' impact on HIV programs in Africa and calls for a reversal of the decision.

Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades.